Alpha Tau Medical Ltd Ordinary Shares - Class A DRTS 深 滬
已收盤 10-31 16:00:00 美东时间
4.165
+0.125
+3.09%
華盛通- 最 高4.2115
- 今 開4.05
- 成交量 7.99万股
- 最 低 3.89
- 昨 收 4.04
- 總市值 3.54亿
- 52周最高 4.69
- 市盈率 靜 --
- 換手率 0.09%
- 52周最低 2.14
- 委 比 -8.68%
- 總股本 8504.32万
- 歷史最高 20.65
- 量 比 1.19
- 振 幅 7.96%
- 歷史最低 1.75
- 每 手 1
- 風險率 0.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 超配！万事达、Visa、Block获多家机构首予评级；奈飞、德州仪器遭多家机构下调目标价
今日重点评级关注：Canaccord Genuity：维持ATAI Life Sciences"买入"评级，目标价从11美元升至14美元；麦格理：维持Cleanspark"跑赢大市"评级，目标价从20美元升至30美元
10-23 10:06
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.
10-22 22:40
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.
09-03 18:58
Alpha Tau Treats First Patient in U.S. Pancreatic Cancer Trial
An announcement from Alpha Tau Medical Ltd ( ($DRTS) ) is now available. On Sep...
09-02 20:58
Alpha Tau to Participate in Five September Investor Conferences
Mr. Raphi Levy, Alpha Tau Medical's CFO, will participate in five investor conferences in September 2025, including the Citi Biopharma Back to School Summit in Boston and the H.C. Wainwright Global Investment Conference in New York. Alpha Tau develops the Alpha DaRT technology, an innovative alpha-radiation therapy for solid tumors, with potential synergistic effects with other cancer treatments. The company emphasizes its commitment to advancing...
08-27 12:30
Alpha Tau Medical Q2 EPS $(0.13) Misses $(0.12) Estimate
Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.12) by 13.04 percent. This is a 18.18 percent decrease over losses of $(0.11) per share
08-12 05:26
Alpha Tau Medical GAAP EPS of -$0.22
Alpha Tau Medical press release (NASDAQ:DRTS): Q2 GAAP EPS of -$0.22. As of June 30, 2025, the Company had cash and cash equivalents, short-term deposits and restricted deposits of $83.3 million, comp...
08-12 04:28
Alpha Tau files to sell 3.46M ordinary shares by selling shareholders
Alpha Tau (NASDAQ:DRTS) filed a prospectus to sale 3.46 million ordinary shares. The company will not receive any proceeds from the sale of ordinary shares by the selling shareholder. This prospectus ...
06-24 05:08
Alpha Tau to Present at Jefferies Global Healthcare Conference
<br>Alpha Tau Medical Ltd.'s CFO, Raphi Levy, will present at the Jefferies Global Healthcare Conference on June 5, 2025, in New York, NY. The presentation will occur between 1:25 PM and 1:55 PM ET. Mr. Levy will also be available for individual investor meetings. Alpha Tau, an Israeli oncology company founded in 2016, develops Alpha DaRT<sup>®</sup>, an innovative alpha-radiation therapy for solid tumors. The technology, initially developed by r...
05-28 12:30
Alpha Tau Medical Q1 EPS $(0.12) Beats $(0.13) Estimate
Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 9.09 percent decrease over losses of $(0.11) per share from
05-20 04:02
